Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR-100 regulates cell viability and apoptosis by targeting ATM in pediatric acute myeloid leukemia
Yin Sun, Hongxiang Wang, Chibao Luo
Biochemical and Biophysical Research Communications (2019) Vol. 522, Iss. 4, pp. 855-861
Closed Access | Times Cited: 12

Showing 12 citing articles:

MircoRNAs predict and modulate responses to chemotherapy in leukemic patients
Doha El‐Sayed Ellakwa, Mohamed Ahmed Abdelmalek, Mostafa Mostafa, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 7
MicroRNA-99 family in cancer: molecular mechanisms for clinical applications
Yueyuan Wang, Dan Huang, Mingxi Li, et al.
PeerJ (2025) Vol. 13, pp. e19188-e19188
Open Access | Times Cited: 1
The emerging role of miRNAs in biological aging and age-related diseases
Rawad Turko, Amro Hajja, Ahmad M. Magableh, et al.
Non-coding RNA Research (2025)
Open Access
Multiomics analysis revealed miRNAs as potential regulators of the immune response in Carassius auratus gills to Aeromonas hydrophila infection
Jiaxin Huo, Xiucai Hu, Jie Bai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review
Bahareh Shateri Amiri, Neda Sabernia, Behdokht Abouali, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 5
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model
İlayda Alçıtepe, Hilal Salcın, İlknur Karatekin, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 6
GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-ITD leukemia cells
Jing Xia, Shuxian Feng, Jian Zhou, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Open Access | Times Cited: 3
Distinct associations of NEDD4L expression with genetic abnormalities and prognosis in acute myeloid leukemia
Ming‐qiang Chu, Liu-chao Zhang, Qian Yuan, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Effects of glyphosate exposure on the miRNA expression profile and construction of the miRNA-mRNA regulatory network in mouse bone marrow cells
Jinyan Liu, Manman Liu, Fei Xiong, et al.
Functional & Integrative Genomics (2022) Vol. 23, Iss. 1
Closed Access | Times Cited: 1
GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-ITD leukemia cells
Tianyu Li, Jing Xia, Shuxian Feng, et al.
Research Square (Research Square) (2022)
Open Access
HDAC Inhibitor Vorinostat and BET Inhibitor Plx51107 Epigenetic Agents’ Combined Treatments Exert a Therapeutic Approach Upon Acute Myeloid Leukemia Cell Model
İlayda Alçıtepe, Hilal Salcın, İlknur Karatekin, et al.
Research Square (Research Square) (2022)
Open Access
Engaging of the mTOR signaling pathway by miR100 and miR101 in de novo acute myeloid leukemia
Maryam Kargar, Mehdi Allahbakhshian Farsani, Javad Garavand, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top